BACKGROUND: The role of leptin in reproductive processes has received increasing attention. Because leptin has intrinsic angiogenic properties, may be induced by inflammatory cytokines and induces matrix metalloproteinases, we examined peritoneal fluid (PF) leptin concentrations in women with endometriosis. METHODS: PF samples were collected from 60 women undergoing laparoscopy for endometriosis, and 18 controls undergoing tubal sterilization. Fifty of the women with endometriosis had received no prior hormonal treatment, while 10 with moderate- severe endometriosis were using GnRH agonists. RESULTS: Women with untreated endometriosis had significantly higher (mean +/- SD) PF leptin levels (34.9 +/- 7.9 ng/ml) than controls (17.9 +/- 4.1 ng/ml; P < 0.001). However, PF leptin levels were inversely correlated with the stage of disease (r = -0.62; P < 0.001). Nevertheless, women with stage III-IV endometriosis maintained significantly higher PF leptin levels (26.3 +/- 4.8 ng/ml; P < 0.001) than controls. Although PF leptin levels were significantly higher in the secretory versus proliferative phase of the menstrual cycle, they remained higher in both phases in women with untreated endometriosis. PF leptin levels in women on GnRH agonists were similar to controls. CONCLUSIONS: PF leptin levels are elevated in women with endometriosis, but inversely correlated with extent of disease. These findings suggest a potential role for leptin in the pathogenesis of peritoneal endometriosis.
BACKGROUND: The role of leptin in reproductive processes has received increasing attention. Because leptin has intrinsic angiogenic properties, may be induced by inflammatory cytokines and induces matrix metalloproteinases, we examined peritoneal fluid (PF) leptin concentrations in women with endometriosis. METHODS: PF samples were collected from 60 women undergoing laparoscopy for endometriosis, and 18 controls undergoing tubal sterilization. Fifty of the women with endometriosis had received no prior hormonal treatment, while 10 with moderate- severe endometriosis were using GnRH agonists. RESULTS:Women with untreated endometriosis had significantly higher (mean +/- SD) PF leptin levels (34.9 +/- 7.9 ng/ml) than controls (17.9 +/- 4.1 ng/ml; P < 0.001). However, PF leptin levels were inversely correlated with the stage of disease (r = -0.62; P < 0.001). Nevertheless, women with stage III-IV endometriosis maintained significantly higher PF leptin levels (26.3 +/- 4.8 ng/ml; P < 0.001) than controls. Although PF leptin levels were significantly higher in the secretory versus proliferative phase of the menstrual cycle, they remained higher in both phases in women with untreated endometriosis. PF leptin levels in women on GnRH agonists were similar to controls. CONCLUSIONS: PF leptin levels are elevated in women with endometriosis, but inversely correlated with extent of disease. These findings suggest a potential role for leptin in the pathogenesis of peritoneal endometriosis.
Authors: Aaron K Styer; Brian T Sullivan; Mark Puder; Danielle Arsenault; John C Petrozza; Takehiro Serikawa; Sung Chang; Tayyaba Hasan; Ruben R Gonzalez; Bo R Rueda Journal: Endocrinology Date: 2007-10-25 Impact factor: 4.736
Authors: Andrea Prestes Nácul; Sheila Bunecker Lecke; Maria Isabel Edelweiss; Débora Martinho Morsch; Poli Mara Spritzer Journal: Obstet Gynecol Int Date: 2013-03-24
Authors: Helder F Gonçalves; Carolina Zendron; Fernanda S Cavalcante; Verônica Aiceles; Marco Aurélio P Oliveira; Jorge Henrique M Manaia; Márcio A Babinski; Cristiane F Ramos Journal: J Ovarian Res Date: 2015-08-05 Impact factor: 4.234
Authors: Carolina Zendron; Helder F Gonçalves; Fernanda S Cavalcante; Thiago R D Pereira; Alessandra Evangelista; Cristiane F Ramos; Marco Aurelio P Oliveira Journal: J Ovarian Res Date: 2014-01-08 Impact factor: 4.234
Authors: Samvida S Venkatesh; Teresa Ferreira; Stefania Benonisdottir; Nilufer Rahmioglu; Christian M Becker; Ingrid Granne; Krina T Zondervan; Michael V Holmes; Cecilia M Lindgren; Laura B L Wittemans Journal: PLoS Med Date: 2022-02-01 Impact factor: 11.613